Medication evidence profile
Tuberculin Purified Protein Derivative
Clinical overview
Tuberculin Purified Protein Derivative has public medication-list entries in GABS 2018 and KABS 2020 open validation supplement. These are 2 separate source versions, each with its own evidence and definitions.
Source-specific scores
| Source | Score |
|---|---|
| JARS | Not listed |
| Yamada-ABS | Not listed |
| BAAS | Not listed |
| Swe-ABS | Not listed |
| GABS | 0 |
| KABS | 0 |
| CALS | Not listed |
How to read this: 0 means the source explicitly assigned zero. “Not listed” means the source did not provide a score for this medication. Scores from different scales are not averaged.
Other names used in the sources
tuberculin purified protein derivate
How to interpret the evidence
2 of 7 public source versions contain an explicit medication-list entry for tuberculin purified protein derivative.
The available rows for tuberculin purified protein derivative display the same numeric value. Agreement of the displayed numbers does not establish identical methods, clinical meaning or patient-level risk.
GABS 2018 and KABS 2020 open validation supplement explicitly record zero. Those recorded zeros remain different from a missing entry.
Source labels and provenance · 2 observations
- German Anticholinergic Burden Score 2018
Source label: Tuberculin Purified Protein Derivate. Published value: 0.
Source version: GABS-2018
Source location: 12877_2018_929_MOESM1_ESM.docx Table S3 row 343
Observation: GABS_2018_R0493; rating state: published_zero. - KABS 2019 scale - 2020 open validation supplement
Source label: Tuberculin Purified Protein Derivate. Published value: 0.
Source version: KABS-2020-validation-supplement
Source location: Additional file 1; category Miscellaneous; table row 97
Observation: KABS2020_SUPP_0491; rating state: published_zero.
What this page does not establish
- No medication-list entry is available here from JARS 2025, Yamada-ABS 2023, BAAS 2019, Swe-ABS 2023, and CALS 2022 Table 4. These gaps remain “Not listed”; no score is inferred from another source or from class membership.
- Do not infer route equivalence from canonical grouping; use source label/table annotations.
- These source records do not estimate an individual’s probability of harm or establish whether to start, stop or change a medication. Ordinal source scores are not averaged into a UnifiedACB score.
References
- Kiesel EK, Hopf YM, Drey M. An anticholinergic burden score for German prescribers: score development. BMC Geriatr. 2018;18(1):239. doi:10.1186/s12877-018-0929-6. Open source
- Suh Y, Ah YM, Han E, et al. Dose response relationship of cumulative anticholinergic exposure with incident dementia: validation study of Korean anticholinergic burden scale. BMC Geriatr. 2020;20(1):265. doi:10.1186/s12877-020-01671-z. Open source
Ask a follow-up
Go to your medication comparison · How UnifiedACB handles disagreement
Ask about this medication
Medication context: Tuberculin Purified Protein Derivative
Ask about this medication